Sign Out
Skeletal Muscle Effects: Cases myopathy and rhabdomyolysis with acute renal failure secondary to myoglobinuria have been reported with HMG-CoA reductase inhibitors, including Rosuvastatin.
These risks can occur at any dose level, but are increased at the highest dose (40 mg).
